MERSATEL ARITMIYA: ETIOLOGIYA, PATOGENEZ VA DAVOLASH TAMOYILLARI

Mardonova Ruxsora Sodikjonovna; Yorqulova Zarina Rahmatjon qizi; Xujankulova Sabina Asqarovna

Authors

Mardonova Ruxsora Sodikjonovna Samarqand Davlat Tibbiyot Universiteti DKTF terapiya, kardiologiya va funksional diagnostika kafedrasi klinik ordinatori
Yorqulova Zarina Rahmatjon qizi Samarqand Davlat Tibbiyot Universiteti DKTF terapiya, kardiologiya va funksional diagnostika kafedrasi klinik ordinatori
Xujankulova Sabina Asqarovna Samarqand Davlat Tibbiyot Universiteti DKTF terapiya, kardiologiya va funksional diagnostika kafedrasi klinik ordinatori

Keywords:

Mersatel aritmiya, bo‘lmachalar fibrillyatsiyasi, etiologiya, patogenez, yurak ritmi buzilishi, gemodinamika, tromboemboliya, diagnostika, davolash.

Abstract

Ushbu maqolada mersatel aritmiya (bo‘lmachalar fibrillyatsiyasi)ning kelib chiqish sabablari, rivojlanish mexanizmlari va klinik kechishi yoritilgan. Kasallikning asosiy etiologik omillari, jumladan yurak-qon tomir tizimi kasalliklari, metabolik buzilishlar hamda nerv-gumoral ta’sirlar tahlil qilinadi. Shuningdek, mersatel aritmiyaning yurak gemodinamikasiga ta’siri, tromboembolik asoratlar rivojlanishidagi o‘rni va ularni oldini olish masalalari ko‘rib chiqiladi. Maqolada zamonaviy diagnostika usullari hamda davolash tamoyillariga umumiy tavsif berilib, kasallikni erta aniqlash va kompleks yondashuvning ahamiyati ta’kidlanadi.

References

1. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2019.

2. Zipes D.P., Jalife J. Cardiac Electrophysiology: From Cell to Bedside. 7th ed. Philadelphia: Elsevier; 2018.

3. January C.T., Wann L.S., Calkins H. et al. 2019 AHA/ACC/HRS guideline for the management of atrial fibrillation. Circulation. 2019;140(2):e125–e151.

4. Kirchhof P., Benussi S., Kotecha D. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal. 2020;42(5):373–498.

5. Fuster V., Walsh R.A., Harrington R.A. Hurst’s The Heart. 14th ed. New York: McGraw-Hill; 2017.

6. Camm A.J., Lip G.Y.H., De Caterina R. et al. Focused update of the ESC Guidelines on atrial fibrillation. European Heart Journal. 2018;39(16):1330–1393.

7. Lip G.Y.H., Tse H.F. Management of atrial fibrillation. The Lancet. 2007;370(9587):604–618.

8. Kannel W.B., Abbott R.D., Savage D.D. Epidemiologic features of atrial fibrillation. The New England Journal of Medicine. 1982;306(17):1018–1022.

9. Wyse D.G., Waldo A.L., DiMarco J.P. et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. NEJM. 2002;347(23):1825–1833.

10. Gorenek B., Blomström Lundqvist C., Brugada Terradellas J. et al. Atrial fibrillation and heart failure. Europace. 2014;16(3):305–312.